Mackay Shields LLC has filed its 13F form on February 03, 2025 for Q4 2024 where it was disclosed a total value porftolio of $499 Million distributed in 367 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Nuveen Amt Free Quality Municipal Income Fund with a value of $45.6M, Nuveen Municipal Credit Income Fund with a value of $37.1M, Ishares Gold Trust with a value of $34.2M, Talos Energy Inc. with a value of $30.4M, and Nuveen Amt Free Municipal Credit Income Fund with a value of $30.2M.
Examining the 13F form we can see an decrease of $82.5M in the current position value, from $581M to 499M .
Below you can find more details about Mackay Shields LLC portfolio as well as his latest detailed transactions.
Portfolio value
$499 Million
$357 Million
$48.3 Million
$47.6 Million
$27.4 Million
$17.6 Million
$408,000
Stock Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 1.15%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 2.16%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 9.15%
-
$0
0.0% of portfolio
-
Q1 2023
Added 140.0%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 12.87%
-
$0
0.0% of portfolio
-
Q2 2024
Added 3.94%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 1.77%
American Airlines Group Inc
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.28%
Amphastar Pharmaceuticals In
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 0.93%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 0.88%
Ares Management Corporation
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 31.58%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 1.68%
-
$0
0.0% of portfolio
-
Q4 2024
Added 1.14%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 99.28%
Biomarin Pharmaceutical Inc
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 14.93%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 5.64%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.59%
Ionis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 11.08%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 0.56%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 1.01%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.08%
Live Nation Entertainment In
-
$0
0.0% of portfolio
-
Q4 2024
New
Live Nation Entertainment In
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 86.56%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 90.81%
Marriott Vacations Worldwide
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.75%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 1.53%
Mirum Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 15.85%
Ionis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 0.68%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.35%
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 15.05%
Envista Holdings Corporation
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 1.4%
-
$0
0.0% of portfolio
-
Q4 2023
Added 3.52%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 13.04%
-
$0
0.0% of portfolio
-
Q4 2024
Added 5.95%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 15.61%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.23%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 1.57%
Halozyme Therapeutics Inc
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 0.83%
Hewlett Packard Enterprise C
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 1.19%
-
$0
0.0% of portfolio
-
Q2 2024
New
